2024-06-15 23:43:21 ET
Summary
- Enfusion targets to grow its top line at a faster pace by optimizing its customer mix.
- Positive operating leverage and an increase in operating efficiency will support higher EBITDA margins for Enfusion.
- I expect ENFN to achieve revenue growth acceleration and profitability improvement in the future, and this supports a Buy rating.
Elevator Pitch
I have a Buy rating assigned to Enfusion, Inc. ( ENFN ) shares....
Read the full article on Seeking Alpha
For further details see:
Enfusion: Expectations Of Faster Growth And Higher Margins Justify A Buy Rating